newsfilter
← Latest News
PR Newswire·

Tetra Bio-Pharma Provides Update on Clinical Development Program for QIXLEEF™

OTTAWA, ON, Oct. 14, 2021 /PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTCQB:TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development today provided an update on the progress and significant achie